Stronger Neo-Minophagen C injection
Marketed by Dexa Medica
Ingredients in every 20 ml
|Glycyrrhizic acid||40 mg|
Each package contains
|ATC Level 1||A - Alimentary tract and metabolism|
|ATC Level 2||A05 - Bile and Liver Therapy Drugs|
|ATC Level 3||A05C - Drugs for Bile Therapy and Lipotropics in Combination|
In chronic hepatic diseases, the daily dosage is from 40 to 60 ml once a day by intravenous injection or intravenous drip infusion. The dosage may be adjusted depending on patient's age and symptom. If an increased dosage id necessary, the daily dosage should be kept within the limit of 100 ml.
In the experience of the clinical use, the occuring frequency of the adverse reactions such as hypopotassemia tends to be higher in the elderly. Careful administration shold be required with observation of patient's condition.
Improvement of abnormal hepatic function in chronic hepatic diseases.